RED BANK, N.J. -- Ansell Healthcare Products Inc. introduces its new Ansell Performance polyisoprene (PI) surgical glove. The latex-free and powder-free glove features many of the benefits associated with natural rubber latex products, including superior barrier protection, and exceptional dexterity and sensitivity. It is intended for general-purpose use.
Polyisoprene is the material most similar to latex available in the glove
market today. Ansell Performance PI gloves offer the high level of puncture resistance, excellent elasticity, strength and durability associated with latex gloves, without the risks of latex allergies. The gloves also have a lightly textured finish for superior grip and
exceptional touch sensitivity, and are color-coded green to be easily
distinguished as latex-free.
The environmental impact of disposal is an important issue in the medical supply industry. Polyisoprene produces only water and carbon dioxide upon incineration, making it more environmentally friendly than most synthetics, including neoprene and vinyl, which release hydrochloric acid.
The Ansell Performance PI general-purpose surgical glove is the first offering in the company's new polyisoprene product line. They will be adding additional polyisoprene gloves to the line in the future, including a heavier, thicker glove for orthopedic surgery and a delicate, thinner glove for cardiothoracic and opthalmic diagnostic microsurgeries.
Ansell Healthcare Products Inc. is a global leader in healthcare barrier protective products.
Source: Ansell Healthcare Products Inc.
Point-of-Care Engagement in Long-Term Care Decreasing Infections
November 26th 2024Get Well’s digital patient engagement platform decreases hospital-acquired infection rates by 31%, improves patient education, and fosters involvement in personalized care plans through real-time interaction tools.
The Leapfrog Group and the Positive Effect on Hospital Hand Hygiene
November 21st 2024The Leapfrog Group enhances hospital safety by publicizing hand hygiene performance, improving patient safety outcomes, and significantly reducing health care-associated infections through transparent standards and monitoring initiatives.
CDC HICPAC Considers New Airborne Pathogen Guidelines Amid Growing Concerns
November 18th 2024The CDC HICPAC discussed updates to airborne pathogen guidelines, emphasizing the need for masks in health care. Despite risks, the committee resisted universal masking, highlighting other mitigation strategies
The Importance of Hand Hygiene in Clostridioides difficile Reduction
November 18th 2024Clostridioides difficile infections burden US healthcare. Electronic Hand Hygiene Monitoring (EHHMS) systems remind for soap and water. This study evaluates EHHMS effectiveness by comparing C difficile cases in 10 hospitals with CMS data, linking EHHMS use to reduced cases.
Breaking the Cycle: Long COVID's Impact and the Urgent Need for Preventative Measures
November 15th 2024Masking, clean air, and vaccinations are essential in combating COVID-19 and preventing long-term impacts, as evidence mounts of long COVID's significant economic, cognitive, and behavioral effects.